Agios Pharmaceuticals Inc (AGIO)

Finanzdaten der Agios Pharmaceuticals Inc-Aktie (AGIO)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	115.68%44.75	20.75	19.97	12.88	12.46
Cost Of Revenue	127.14%3.00	1.32	1.88	1.68	1.70
	6.71%51.55	48.30	-	-	-
Selling, General, and Administrative	6.71%51.55	48.30	-	-	-
Research and Development	24.16%100.75	81.15	-	-	-
Costs And Expenses	18.75%155.30	130.77	141.55	129.75	139.51
Operating Income/Loss	0.48%-110.55	-110.03	-121.58	-116.87	-127.06
	1.61%-100.70	-99.11	-108.04	-103.43	-112.02
Attributable To Parent	1.61%-100.70	-99.11	-108.04	-103.43	-112.02
Basic Average Shares	1.20%59.49	58.78	0.13	58.14	57.93
Diluted Average Shares	1.20%59.49	58.78	0.13	58.14	57.93
Basic Earnings Per Share	-1.69	-1.69	-1.85	-1.78	-1.93
Diluted Earnings Per Share	-1.69	-1.69	-1.85	-1.78	-1.93